IMM 1.45% 34.0¢ immutep limited

igcs abstract, page-15

  1. 244 Posts.
    no problem. lets see what the interim data has to say. then we can hopefully make some sort of judgement

    i will warn you, and everyone else reading, that data in the phase III trial is not available to the Prima team. So, if it is recruiting, don't assume that CANVAS is working, it is overseen by an independent panel whose interest is pertaining to scientific validity
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.